Share

BioMarin CEO says study results for hemophilia gene therapy are as 'good as we could hope'

Jean-Jacques Bienaime, CEO and chairman of BioMarin Pharmaceutical, appeared on Tuesday's episode of "Mad Money," discussing trial results for the company's hemophilia gene therapy.
02:40
Tue, Jan 11 20227:18 PM EST